Annual hepatocellular carcinoma (HCC) incidence rates according to age and sex
| Age (y) | F0/1 | F2 | F3 | F4 |
|---|---|---|---|---|
| The percentages indicate the annual incidence rates fitted by the least squares method using the risk ratios shown in table 4. Numbers in parentheses are the observed events/number at risk in each category. | ||||
| SVR, sustained virological response; F0–F4, fibrosis stage. | ||||
| SVR, male | ||||
| ⩽39 | 0.05% (0/65) | 0.09% (0/59) | 0.16% (0/14) | 0.24% (0/4) |
| 40–49 | 0.05% (0/57) | 0.09% (0/66) | 0.16% (1/29) | 0.24% (0/9) |
| 50–59 | 0.39% (0/38) | 0.69% (3/62) | 1.21% (5/51) | 1.86% (1/18) |
| 60+ | 0.70% (3/29) | 1.18% (3/38) | 2.01% (4/35) | 3.20% (1/9) |
| SVR, female | ||||
| ⩽39 | 0.02% (0/32) | 0.05% (0/38) | 0.10% (0/7) | 0.15% (0/1) |
| 40–49 | 0.03% (0/25) | 0.05% (0/23) | 0.10% (0/3) | 0.15% (1/1) |
| 50–59 | 0.23% (0/20) | 0.41% (1/33) | 0.73% (1/20) | 1.12% (1/6) |
| 60+ | 0.40% (0/6) | 0.71% (1/18) | 1.25% (0/14) | 1.93% (1/6) |
| Non-SVR, male | ||||
| ⩽39 | 0.05% (0/83) | 0.13% (0/72) | 0.28% (2/29) | 0.56% (0/6) |
| 40–49 | 0.35% (2/85) | 1.00% (4/101) | 2.16% (7/46) | 4.26% (10/32) |
| 50–59 | 0.82% (6/82) | 2.33% (19/111) | 5.06% (26/74) | 10.0% (17/33) |
| 60+ | 1.03% (4/36) | 2.93% (13/59) | 6.35% (17/64) | 12.5% (15/29) |
| Non-SVR, female | ||||
| ⩽39 | 0.02% (0/37) | 0.07% (0/21) | 0.14% (0/10) | 0.29% (0/2) |
| 40–49 | 0.18% (0/41) | 0.51% (2/44) | 1.10% (3/18) | 2.17% (0/6) |
| 50–59 | 0.42% (1/53) | 1.19% (8/96) | 2.57% (19/80) | 5.08% (5/32) |
| 60+ | 0.52% (1/23) | 1.49% (11/64) | 3.23% (10/60) | 6.37% (12/27) |